On November 4, baolingbao (002286.SZ) stated on the investor interaction platform that the company has currently expanded the application of erythritol and maltodextrin, both of which have pharmaceutical excipient qualifications, in the field of medicine.
保龄宝(002286.SZ)：已拓展赤藓糖醇、麦芽糊精具有药用辅料资质的产品在医药领域的应用
baolingbao (002286.SZ): products with pharmaceutical excipient qualifications such as erythritol and maltodextrin have been expanded for application in the pharmaceutical field.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated